Annual Cash & Cash Equivalents
$143.82 M
-$44.64 M-23.69%
December 31, 2023
Summary
- As of February 7, 2025, AVIR annual cash & cash equivalents is $143.82 million, with the most recent change of -$44.64 million (-23.69%) on December 31, 2023.
- During the last 3 years, AVIR annual cash & cash equivalents has fallen by -$706.29 million (-83.08%).
- AVIR annual cash & cash equivalents is now -83.08% below its all-time high of $850.12 million, reached on December 31, 2020.
Performance
AVIR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$98.46 M
-$144.93 M-59.55%
September 30, 2024
Summary
- As of February 7, 2025, AVIR quarterly cash and cash equivalents is $98.46 million, with the most recent change of -$144.93 million (-59.55%) on September 30, 2024.
- Over the past year, AVIR quarterly cash and cash equivalents has dropped by -$39.42 million (-28.59%).
- AVIR quarterly cash and cash equivalents is now -88.42% below its all-time high of $850.12 million, reached on December 31, 2020.
Performance
AVIR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AVIR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.7% | -28.6% |
| 3 y3 years | -83.1% | -28.6% |
| 5 y5 years | +317.0% | -28.6% |
AVIR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.2% | at low | -87.1% | at low |
| 5 y | 5-year | -83.1% | +564.0% | -88.4% | +354.6% |
| alltime | all time | -83.1% | +564.0% | -88.4% | +354.6% |
Atea Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $98.46 M(-59.5%) |
| Jun 2024 | - | $243.39 M(+51.3%) |
| Mar 2024 | - | $160.91 M(+11.9%) |
| Dec 2023 | $143.82 M(-23.7%) | $143.82 M(+4.3%) |
| Sep 2023 | - | $137.89 M(-35.5%) |
| Jun 2023 | - | $213.70 M(+16.6%) |
| Mar 2023 | - | $183.25 M(-2.8%) |
| Dec 2022 | $188.46 M | $188.46 M(+6.8%) |
| Sep 2022 | - | $176.41 M(-74.2%) |
| Jun 2022 | - | $684.48 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $705.54 M(-7.7%) |
| Dec 2021 | $764.38 M(-10.1%) | $764.38 M(-9.0%) |
| Sep 2021 | - | $839.66 M(+2.8%) |
| Jun 2021 | - | $816.46 M(-2.1%) |
| Mar 2021 | - | $833.75 M(-1.9%) |
| Dec 2020 | $850.12 M(+3824.6%) | $850.12 M(+706.7%) |
| Sep 2020 | - | $105.38 M(-9.0%) |
| Jun 2020 | - | $115.79 M(+434.6%) |
| Dec 2019 | $21.66 M(-37.2%) | $21.66 M |
| Dec 2018 | $34.49 M | - |
FAQ
- What is Atea Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Atea Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Atea Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of AVIR is $143.82 M
What is the all time high annual cash & cash equivalents for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual cash & cash equivalents is $850.12 M
What is Atea Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, AVIR annual cash & cash equivalents has changed by -$44.64 M (-23.69%)
What is Atea Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AVIR is $98.46 M
What is the all time high quarterly cash and cash equivalents for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly cash and cash equivalents is $850.12 M
What is Atea Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, AVIR quarterly cash and cash equivalents has changed by -$39.42 M (-28.59%)